⌕
Sotera Health · SHC · Nasdaq
Tenet 46 · Mixed
Compare
$16.25−2.17%At closeTenet 46 · Mixed
$16.25−0.36 (−2.17%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Sotera Health (SHC) Stock Checks

How SHC measures up against value, income, timing, and long-hold tenets. Every criterion shows the number as of the last close and the pass rule. Always free.

Sources Company filings and computed by Tenet Filings and TenetScreens as of How we compute thisNot investment advice

The tenets below and the 0-100 Tenet Score on this report are two separate computations: each tenet runs its own criteria and its own pass rule, while the score is a percentile composite reported as one of four verdict words (Strong, Solid, Mixed or Weak).

1 / 17 qualify todayas of close, Nov 13, 2026 · computed nightly from our fundamentals DB; point-in-time auditable.
QUALIFIES
1
meet every gate today
BORDERLINE
4
within one input of the gate
FAILS
9
miss at least one gate
UNKNOWN
3
insufficient data to judge
Buffett Qualitydurable moat
~ Borderline
PassesROE ≥ 15%15.4% · ≥ 15.0%
PassesGross margin ≥ 40%55.5% · ≥ 40.0%
FailsNet margin ≥ 15%6.7% · ≥ 15.0%
FailsDebt/equity ≤ 0.53.70 · ≤ 0.50
PassesGrowing FCF (multi-yr)17.3% · > 0
Decided by the pass rule for Buffett Quality.
The pass rule for Buffett Quality is what decides that verdict, and it is not restated here.Buffett Quality under The screens ›Today's Buffett Quality list ›
PassesReturn on assets positive2.4% · > 0
PassesOperating cash flow positive$287.2M · > 0
PassesReturn on assets improving1.4% → 2.4%
PassesEarnings backed by cash (CFO > net income)$287.2M vs $77.9M
PassesLeverage falling (long-term debt / assets)71.9% → 65.2%
FailsCurrent ratio improving2.75 → 2.46
PassesNo share dilution (≤ +2%)+0.5%
PassesGross margin expanding54.7% → 55.5%
FailsAsset turnover improving0.36 → 0.36
Decided by the pass rule for Piotroski F-Score.
The pass rule for Piotroski F-Score is what decides that verdict, and it is not restated here.Piotroski F-Score under The screens ›Today's Piotroski F-Score list ›
FailsROIC ≥ 15%7.0% · ≥ 15.0%
FailsNet debt/EBITDA ≤ 3×3.6× · ≤ 3.0×
FailsAltman Z ≥ 3 (safe zone)1.70 · ≥ 3.00
Decided by the pass rule for Munger Compounders.
The pass rule for Munger Compounders is what decides that verdict, and it is not restated here.Munger Compounders under The screens ›Today's Munger Compounders list ›
PassesEBIT > 0$362.0M · > 0
FailsEarnings yield EBIT/EV ≥ 6%5.5% · ≥ 6.0%
FailsReturn on capital ≥ 25%24.2% · ≥ 25.0%
Decided by the pass rule for Magic Formula.
The pass rule for Magic Formula is what decides that verdict, and it is not published separately on the methodology page.About this screen ›Today's Magic Formula® list ›
PassesSize: market cap ≥ $2B$4.7B · ≥ $2.0B
PassesCurrent ratio ≥ 22.46 · ≥ 2.00
FailsPositive EPS 6yWe hold no record of earnings per share or net income for fiscal 2022, so that year is left out and this test covers the 6 fiscal years we can judge.4y
FailsPays a dividend$0.00 · > 0
FailsEPS growth ≥ 3%/yr−10.2% · ≥ 3.0%
FailsP/E ≤ 1561.03 · ≤ 15.00
FailsP/E × P/B ≤ 22.5477.79 · ≤ 22.50
Decided by the pass rule for Graham Defensive.
The pass rule for Graham Defensive is what decides that verdict, and it is not restated here.Graham Defensive under The screens ›Today's Graham Defensive list ›
Unknown — no dataPEG < 1 (hist. growth)— · < 1.00
FailsEPS growth 10–30%−10.2% · 10.0%–30.0%
Verdict Unknown for this set.
Verdict Unknown for this set. 1 of 2 checks below carry data.Lynch GARP under The screens ›Today's Lynch GARP list ›
FailsPays a dividend$0.00 · > 0
Unknown — no dataYield in a healthy band (not a yield trap)0.0% · 1.0%–8.0%
Unknown — no dataCovered by free cash flow— · ≥ 1.20
Unknown — no dataEarnings payout not stretched— · ≤ 75.0%
Unknown — no dataBalance sheet can sustain the payout3.6× · ≤ 4.0×
Verdict Unknown for this set.
Verdict Unknown for this set. 1 of 5 checks below carry data. The pass rule for Income & Dividend Safety is not published separately on the methodology page.
FailsPays a dividend$0.00 · > 0
Unknown — no dataAnnual dividend raised 10+ years running (Aristocrat ≥25, King ≥50)— · ≥ 10.00
Unknown — no dataNo dividend cut in the last 5 years—
Unknown — no data5-year dividend growth ≥ 5%/yr— · ≥ 5.0%
Unknown — no dataCovered by free cash flow— · ≥ 1.20
Unknown — no dataPayout not stretched— · ≤ 75.0%
Verdict Unknown for this set.
Verdict Unknown for this set. 1 of 6 checks below carry data.Dividend Growth under The screens ›Today's Dividend Growth list ›
FailsReturn on invested capital ≥ 15% in 4+ of the last 5 years0 of 4 on file
FailsRevenue compounding ≥ 8%/yr over 5 years7.3% · ≥ 8.0%
FailsNot diluting: diluted share count flat-to-down (≤ +1%/yr)3.5% · ≤ 1.0%
PassesFree cash flow margin ≥ 12%12.8% · ≥ 12.0%
PassesEarnings backed by cash (operating cash flow ≥ net income)3.68 · ≥ 1.00
Reading: does not hold. Not a gate checkDisciplined buybacks: actively reducing the share count (bonus)reading, not a gate check3.5%
Decided by the pass rule for Quality Compounder.
The pass rule for Quality Compounder is what decides that verdict, and it is not restated here. Lines marked as readings are published beside the checks and are not gate checks.Quality Compounder under The screens ›Today's Quality Compounder list ›
PassesOff its 52-week high by 8–35% (a dip, not a collapse)16.3% · 8.0%–35.0%
PassesDip within its own normal pullback band0.16
FailsNot past where its dips have historically recovered from1.97
FailsA dip in an uptrend (above a rising 200-day)16.89
FailsHigher-low structure still intactstructure broken · no higher low
Unknown — no dataClear of the earnings blackout (more than 5 days out)— · > 5.00
Decided by the pass rule for Drawdown Context.
The pass rule for Drawdown Context is what decides that verdict, and it is not published separately on the methodology page. 1 of 6 carry no data.
FailsA bullish MACD cross within 10 sessions16.00 · ≤ 10.00
FailsReclaimed a rising 50-day EMA17.65
FailsPrinted a higher lowno
FailsA volume thrust on the turn (≥ 1.2× normal)0.96 · ≥ 1.20
FailsReversal signals fired: 3 of 4 (MACD·MA·HL·Vol)0.00 · ≥ 3.00
Decided by the pass rule for Reversal Evidence.
The pass rule for Reversal Evidence is what decides that verdict, and it is not published separately on the methodology page.
PassesIn the cheap half of its own 5-year valuation range0.4×
PassesEarnings estimates not being cut0.02
PassesReturns on capital not deteriorating0.07
Decided by the pass rule for Not-a-Value-Trap Gate.
The pass rule for Not-a-Value-Trap Gate is what decides that verdict, and it is not published separately on the methodology page.
PassesOperating profit is positive$362.0M · > 0
FailsReturn on invested capital ≥ 10%7.0% · ≥ 10.0%
FailsA solvent balance sheet (Altman Z ≥ 1.8, net debt/EBITDA ≤ 4)1.7×
PassesQuality score ≥ 5060.40 · ≥ 50.00
PassesRevenue growing over 5 years7.3% · > 0
Decided by the pass rule for Quality Floor.
The pass rule for Quality Floor is what decides that verdict, and it is not published separately on the methodology page.
A research signal from published criteria, not a recommendation.
FailsDrawdown context16.3% off its 52-week high
FailsReversal evidence0 of 4 signals fired
PassesTrap gate3 of 3 held
FailsQuality floor3 of 5 held
Invalidation level (structure break): below this the dip's structure has broken$17.64
Decided by the pass rule for Qualified Dip.
The pass rule for Qualified Dip is what decides that verdict, and it is not restated here.Qualified Dip under The screens ›Today's Qualified Dip list ›
FailsTrading above its 50-day average17.96
FailsTrading above its 200-day average16.89
Passes50-day average above the 200-day (uptrend stack)17.96
Fails50-day average sloping up−0.04 · > 0
Decided by the pass rule for Trend Alignment.
The pass rule for Trend Alignment is what decides that verdict, and it is not published separately on the methodology page.
Fails3-month return in the top half of the universe0.30 · ≥ 0.50
Passes12-minus-1 momentum in the top half of the universe0.54 · ≥ 0.50
FailsRelative strength vs the S&P 500 improving−0.00 · > 0
PassesEarnings estimates being revised up0.02
Decided by the pass rule for Relative Strength.
The pass rule for Relative Strength is what decides that verdict, and it is not published separately on the methodology page.
FailsMACD above its signal line−0.52
FailsBack above the 50-day on a fresh cross (≤10 sessions)16.00
FailsHigher high and higher low (stair-stepping up)no higher high · no higher low
FailsA volume thrust on the move (≥ 1.2× normal)0.96 · ≥ 1.20
Decided by the pass rule for Momentum Trigger.
The pass rule for Momentum Trigger is what decides that verdict, and it is not published separately on the methodology page.
Average daily swing: elevated0.03
Volatility band width: expanded (wide range)0.91
Distance from its 52-week high: mid-range0.16
Every verdict is auditableEach criterion shows the number as of the last close and the pass rule side by side: a receipt, not a rating. Several of these screens publish their rule in full under The screens; each row links to its own section where there is one.
Unknown ≠ failAn “— Unknown” verdict means the inputs were insufficient: context, not a signal, and never counted as a fail.

How many investing rule sets does Sotera Health pass?

Sotera Health qualifies on 1 of 17 rule sets as of 2026-11-13, with 4 borderline and 9 failing.

Does Sotera Health meet the Graham Defensive criteria?

Sotera Health fails the Graham Defensive rule set as of 2026-11-13.

Does Sotera Health meet the Buffett Quality criteria?

Sotera Health is borderline on the Buffett Quality rule set as of 2026-11-13.

Computed from our fundamentals DB; historical-CAGR PEG basis for Lynch. Research, not investment advice. Tenet's rulesets are independently developed from publicly available sources, and Tenet is not affiliated with, sponsored by, endorsed by or otherwise associated with any referenced investor or trademark owner. Full notice. MAGIC FORMULA is a trademark of MagicFormulaInvesting.com LLC.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.